col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


45 Ergebisse       Seite 1

 [1] 
Elsevier: Archives of Cardiovascular Diseases
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mrz―18 Prognosis of patients with acute myocardial infarction in the setting of COVID-19: A French nationwide observational study Ahmad Abou Hamed, Maeva Gourraud, Thibaud Genet, François Barbier, Denis Angoulvant, Laurent Fauchier, Fabrice Ivanes
2 [GO] 2024―Jun―26 SARS-CoV-2 infection leads to pulmonary vascular remodeling in transgenic mice expressing hACE2 in vascular cells Angèle Frisdal, Serban Morosan, Christelle Enond, Stéphane Sylvain Marot, Anne-Geneviève Marcelin, Stéphane Hatem, Sophie Nadaud
3 [GO] 2024―Jan―08 Impact of the coronavirus disease 2019 pandemic on aortic valve replacement and outcomes in France Graeme Prosperi-Porta, Virginia Nguyen, Helene Eltchaninoff, Julien Dreyfus, Ian G. Burwash, Nadav Willner, et al. (+9)
4 [GO] 2023―Dez―22 Medical students’ evaluation by serious games in the era of Covid-19 infection I. Chamtouri, M. Kechida, W. Jomaa, K. Ben Hamda
5 [GO] 2023―Dez―22 Epicardial ablation of an endomyocardial ventricular tachycardia in the setting of Covid-19 infection S. Hafid, I. Bensahi, N. Elyounoussi, G. M, M. Sabry, R. Habbal
6 [GO] 2023―Dez―22 Prognosis of acute myocardial infarction patients in the setting of COVID-19 : A French observational study A. Abou Hamed, T. Genet, C. Saint-Etienne, D. Angoulvant, L. Fauchier, F. Ivanes
7 [GO] 2023―Dez―22 Lack of temporal correlations between COVID pandemic waves and the occurrence of malignant ventricular arrhythmias D. Foltran, G.-F. Céline, N. Marimpouy, M. Beneyto, G. Domain, M. Pierre, et al. (+5)
8 [GO] 2023―Jun―29 Cardiovascular events in the context of coronavirus disease 2019: Letter in response to “Two-year prognosis of acute coronary syndrome during the first wave of the coronavirus disease 2019 pandemic‿ by Gabrion et al Joseph C. Lee, Jia Wen Chong, Alaa Alghamry
9 [GO] 2023―Jun―29 You can’t prove what you believe: Response to a letter entitled “Cardiovascular events in the context of coronavirus disease 2019‿ from Lee et al Alexis Hermida, Paul Gabrion, Christophe Beyls
10 [GO] 2023―Mrz―25 Two-year prognosis of acute coronary syndrome during the first wave of the coronavirus disease 2019 pandemic Paul Gabrion, Christophe Beyls, Nicolas Martin, Genevieve Jarry, Arthur Facq, Alexandre Fournier, et al. (+9)
11 [GO] 2023―Feb―14 Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation Aurélien Philippe, Richard Chocron, Guillaume Bonnet, Nader Yatim, Willy Sutter, Jérôme Hadjadj, et al. (+16)
12 [GO] 2023―Jan―20 Clinical usefulness of admission versus monitoring troponin in patients with coronavirus disease 2019 Agathe Beauvais, Nicolas Gendron, Aurélien Philippe, Benoit Vedie, Marie-Anne Loriot, Philippe Juvin, et al. (+5)
13 [GO] 2022―Okt―22 Machine learning-based scoring system to predict in-hospital outcomes in patients hospitalized with COVID-19 Orianne Weizman, Baptiste Duceau, Antonin Trimaille, Thibaut Pommier, Joffrey Cellier, Laura Geneste, et al. (+30)
14 [GO] 2022―Okt―22 Endothelial dysfunction in convalescent COVID-19 patients: Systematic review and meta-analysis Panagiotis Theofilis, Stamatios Lampsas, Evangelos Oikonomou, Gerasimos Siasos, Michael Andrew Vavuranakis, Georgios Marinos, et al. (+3)
15 [GO] 2022―Sep―29 Cardiac screening before returning to elite sport after SARS-CoV-2 infection Christophe Hédon, Frédéric Schnell, Philippe Sosner, Frédéric Chagué, Iris Schuster, Marc Julia, et al. (+6)
16 [GO] 2022―Jun―08 Cardiopulmonary predictors of mortality in patients with COVID-19: What are the findings? Hoda Kavosi, Sepehr Nayebi Rad, Reza Atef Yekta, Zahra Tamartash, Mahboubeh Dini, Zahra Javadi Nejad, et al. (+4)
17 [GO] 2022―Mrz―04 Coronary artery calcifications and 6-month mortality in patients with COVID-19 without known atheromatous disease Anne-Sophie Le Hir, Antoine Fayol, Elie Mousseaux, Nicolas Danchin, Victoria Tea, Chekrallah Chamandi, et al. (+2)
18 [GO] 2022―Feb―02 Echocardiography and renin-aldosterone interplay as predictors of death in COVID-19 Joe-Elie Salem, Nadjib Hammoudi, Bruno Pinna, Stephane Ederhy, Antonin Lamazière, Charlotte Fenioux, et al. (+16)
19 [GO] 2021―Dez―13 Care management and 90-day post discharge mortality in patients hospitalized for myocardial infarction and COVID-19: A French nationwide observational study Clémence Grave, Amélie Gabet, Jean-Philippe Empana, Etienne Puymirat, Philippe Tuppin, Nicolas Danchin, Valérie Olié
20 [GO] 2021―Nov―10 Myocardial infarction throughout 1 year of the COVID-19 pandemic: French nationwide study of hospitalization rates, prognosis and 90-day mortality rates Clémence Grave, Amélie Gabet, Etienne Puymirat, Jean-Philippe Empana, Philippe Tuppin, Nicolas Danchin, Valérie Olié
21 [GO] 2021―Okt―30 Prognostic value of pre-hospitalization stress perfusion cardiovascular magnetic resonance to predict death in patients hospitalized for COVID-19 Théo Pezel, Philippe Garot, Thomas Hovasse, Thierry Unterseeh, Stéphane Champagne, Solenn Toupin, et al. (+3)
22 [GO] 2021―Sep―08 COVID-19 vaccine post-marketing surveillance: cardiovascular doctors have a role to play! Dorine Fournier, Amandine Bouchet, Bénédicte Lebrun-Vignes
23 [GO] 2021―Jun―26 COVID-19 vaccines and myocarditis Mathieu Kerneis, Kevin Bihan, Joe-Elie Salem
24 [GO] 2021―Mai―24 COVID-19 cardiological research in France: a nationwide perspective Raffaele De Caterina
25 [GO] 2021―Mai―24 Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring Vincent Galand, Elliot Hwang, Estelle Gandjbakhch, Frédéric Sebag, Eloi Marijon, Serge Boveda, et al. (+4)
26 [GO] 2021―Mai―24 History of heart failure in patients with coronavirus disease 2019: Insights from a French registry Vassili Panagides, Flavien Vincent, Orianne Weizman, Melchior Jonveaux, Antonin Trimaille, Thibaut Pommier, et al. (+25)
27 [GO] 2021―Mai―24 Coronavirus disease vaccination in heart failure: No time to waste Jerome Roncalli, François Roubille, Nicolas Lamblin, Nicolas Girerd, Frédéric Mouquet, Nicolas Chapet, et al. (+11)
28 [GO] 2021―Mai―24 Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children mimicking Kawasaki disease Jean-Christophe Mercier, Naim Ouldali, Isabelle Melki, Romain Basmaci, Michael Levy, Luigi Titomanlio, et al. (+2)
29 [GO] 2021―Mai―21 Characteristics and impact of cardiovascular comorbidities on coronavirus disease 2019 in women: A multicentre cohort study Orianne Weizman, Delphine Mika, Joffrey Cellier, Laura Geneste, Antonin Trimaille, Thibaut Pommier, et al. (+21)
30 [GO] 2021―Apr―15 ST-segment elevation myocardial infarction: management and association with prognosis during the COVID-19 pandemic in France Guillaume Bonnet, Vassili Panagides, Mathieu Becker, Nicolas Rivière, Cédric Yvorel, Antoine Deney, et al. (+35)
31 [GO] 2021―Apr―15 Emergency department admissions for myocardial infarction and stroke in France during the first wave of the COVID-19 pandemic: National temporal trends and regional disparities Valérie Olié, Laure Carcaillon-Bentata, Marie-Michèle Thiam, Sylvie Haeghebaert, Céline Caserio-Schönemann
32 [GO] 2021―Mrz―10 D-dimers at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicentre cohort study Richard Chocron, Baptiste Duceau, Nicolas Gendron, Nacim Ezzouhairi, Lina Khider, Antonin Trimaille, et al. (+28)
33 [GO] 2021―Mrz―02 Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study Guillaume Bonnet, Orianne Weizman, Antonin Trimaille, Thibaut Pommier, Joffrey Cellier, Laura Geneste, et al. (+30)
34 [GO] 2021―Jan―22 Adult cardiac surgery during COVID-19 lockdown: Impact on activity and outcomes in a high-volume centre Joseph Nader, Amedeo Anselmi, Jacques Tomasi, Amandine Martin, Marie Aymami, Simon Rouze, et al. (+5)
35 [GO] 2020―Okt―23 Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis Mathieu Kerneis, Arnaud Ferrante, Paul Guedeney, Eric Vicaut, Gilles Montalescot
36 [GO] 2020―Okt―19 Left ventricular ejection fraction: an additional risk marker in COVID-19 Laurie Soulat-Dufour, Sylvie Lang, Stephane Ederhy, Saroumadi Adavane-Scheuble, Marion Chauvet-Droit, Pascal Nhan, et al. (+5)
37 [GO] 2020―Aug―17 Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2 Bernard I Lévy, Jean Pierre Fauvel
38 [GO] 2020―Jun―25 Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic Pierre Lantelme, Sandrine Couray Targe, Pierre Metral, Thomas Bochaton, Sylvain Ranc, Maggie Le Bourhis Zaimi, et al. (+3)
39 [GO] 2020―Jun―19 The potential sudden shift in clinical research and epidemiology of cardiovascular diseases, caused by COVID-19 Théo Pezel, Joao A.C. Lima
40 [GO] 2020―Jun―18 Acute cardiovascular diseases may be less likely to be considered because of the COVID-19 pandemic - our duty is first to alert, then to analyse more deeply: Response to a letter entitled “Severity of cardiovascular diseases during the COVID-19 pandemic” from T. Imamura Fabien Huet, Cyril Prieur, Guillaume Schurtz, Edouard Gerbaud, Stéphane Manzo-Silberman, Gerald Vanzetto, et al. (+6)
41 [GO] 2020―Jun―18 Nuclear cardiology in the COVID-19 pandemic era Jonathan Vigne, Alain Manrique, Audrey Mouet, Simon Le Hello, Denis Agostini
42 [GO] 2020―Jun―18 Severity of cardiovascular diseases during the COVID-19 pandemic: A letter in response to the article entitled “One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic.” by Huet et al Teruhiko Imamura
43 [GO] 2020―Apr―28 One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic Fabien Huet, Cyril Prieur, Guillaume Schurtz, Edouard Gerbaud, Stéphane Manzo-Silberman, Gerald Vanzetto, et al. (+6)
44 [GO] 2020―Apr―24 Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection Frederic Sacher, Laurent Fauchier, Serge Boveda, Christian de Chillou, Pascal Defaye, Jean Claude Deharo, et al. (+4)
45 [GO] 2020―Mrz―31 COVID-19 in patients with cardiovascular diseases Jean-Sébastien Hulot
 [1] 

45 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec